A Pilot Study of Allogeneic Hematopoietic Stem Cell Transplantation for Intermediated-risk Acute Myeloid Leukemia Patients

Background/Aim: Background/Aim: For intermediate risk acute myeloid leukemia patients, allogeneic hematopoietic stem cell transplantation (alloSCT) and chemotherapy are equally recommended as consolidation after first complete remission (CR1). In real-world, alloSCT might not be readily available, b...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:In Vivo
Autores principales: OH, MI JIN, SHIN, DONG-YEOP, KOH, YOUNGIL, HONG, JUNSHIK, KIM, INHO, YOON, SUNG-SOO, BYUN, JA MIN
Formato: Artigo
Lenguaje:Inglês
Publicado: International Institute of Anticancer Research 2021
Materias:
Research Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7880739/
https://ncbi.nlm.nih.gov/pubmed/33402517
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21873/invivo.12299
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares